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It is well known that obstructive sleep apnoea is especially frequent in the morbidly obese. In these subjects diurnal
chronic hypercapnia, whose mechanism is still debated, may be present.
Our study was performed to evaluate the prevalence and the mechanism of diurnal hypercapnia in the morbidly
obese aected by obstructive sleep apnoea. From a population referred to our centre because of suspicion of sleep
related breathing disorders, we selected 285 subjects without cardiopulmonary, neuromuscular or endocrinological
diseases: 89 (36 M and 53 F, aged 46+13 years) had body mass index (BMI) 40 kg m72 (MO group: morbidly
obese subjects) and 196 (99 M and 97 F, aged 48+16 years) had BMI540 kg m72 (NMO group: non-morbidly
obese subjects). Then the MO group was divided into three subgroups: normocapnic subjects without obstructive
sleep apnoea, normocapnic subjects with obstructive sleep apnoea, hypercapnic subjects with obstructive sleep
apnoea; while we found no hypercapnic subject without obstructive sleep apnoea.
All subjects underwent anthropometric evaluations and bioelectrical impedance analyses, respiratory function
tests and arterial blood gas analysis, a modified version of the Sleep and Healthy Questionnaire and a full night
polysomnography.
Our results showed that hypercapnia (PaCO2 45 mmHg) associated with obstructive sleep apnoea [respiratory
disturbance index (RDI) 10 h–1] was found in 27% of the morbidly obese subjects, but only in 11% of the non-
morbidly obese ones (P5001)
The comparison among the three subgroups, in which we divided the morbidly obese subjects, shows that those
with hypercapnia and obstructive sleep apnoea had significantly more important ventilatory restrictive defects
[forced vital capacity (FVC)% of pred 7327+1481 vs. 8237+1693 vs. 8725+1814 respectively; total lung
capacity (TLC)% of pred 6383+1635 vs. 7911+1415 vs. 8701+105], a significantly higher respiratory
disturbance index (RDI 4634+2690 vs. 3179+2247 vs. 498+329) a longer total sleep time with oxyhaemo-
globin saturation590% [total sleeptime (TST)SaO2590% 6340+3386 vs. 2595+2934 vs. 822+2212] and a lower
rapid eye movement (REM) stage (95+12 vs. 140+09 vs. 1705+12) than normocapnic subjects with
obstructive sleep apnoea or subjects without obstructive sleep apnoea.
The best model to predict PaCO2 resulted from a combination of TSTSaO2590% (r
2=022, P50001), forced
expiratory volume in 1 sec (FEV1)% of pred (r
2=009, P5001), FVC % of pred (r2=0075, P5001).
In conclusion our study suggests that diurnal hypercapnia is frequently associated with obstructive sleep apnoea
in the morbidly obese without chronic obstructive pulmonary disorder (COPD) and that ventilatory restriction and
sleep related respiratory disturbances correlate to diurnal hypercapnia.
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It is well established that obesity is a risk factor for
obstructive sleep apnoea and that the prevalence of this
syndrome is particularly evident in the morbidly obese
(1,2). Daytime chronic hypercapnia occurs in some patients
with obstructive sleep apnoea. Although some authors# 2000 HARCOURT PUBLISHERS LTD
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ing to hypercapnia (3,4), the reason for hypercapnia in
obstructive sleep apnoea remains unknown. In fact there
are patients with obstructive sleep apnoea and severe
obstructive defect with hypercapnia and without hypercap-
nia. The role of obesity in determining diurnal hypercapnia
in obstructive sleep apnoea is still unknown and the results
of several studies are dierent (5,6). Furthermore in the
literature there are not many reports about the influence of
fat distribution on the development of hypercapnia in
subjects with obstructive sleep apnoea (7). The aim of this
study was to evaluate the prevalence and the mechanism of
diurnal hypercapnia in the morbidly obese subjects aected
by obstructive sleep apnoea.
Patients and methods
We studied 465 consecutive subjects referred to our centre
because of a clinical suspicion of sleep related breathing
disorders (SRBD) in 5 years.
All the subjects gave their own informed consent.
From this population, we selected 285 subjects (135 M
and 150 F, aged 475+15 years), without endocrinological
diseases or disorders, narcolepsy or idiopathic hypersom-
nia, neuromuscular diseases or major psychiatric disorders,
overt or primitive cardiopulmonary diseases, airflow
obstruction (FEV1/FVC570%), anatomic maxillo-man-
dibular skeletal anomalies, heavy otorhinolaryngoiatric
pathological findings, history of alcohol or drug abuse.
At the beginning these patients were divided into two
groups, based on body mass index (BMI). Eighty-nine
subjects (36 M and 53 F, aged 46+13 years) had BMI
40 kg m72 (49+65) and were identified as morbidly
obese subjects (MO group); the remaining 196 (99 M and 97
F, aged 48+16 years) had BMI540 kg m72 (32+529) and
were identified as non-morbidly obese subjects (NMO
group). These two groups didn’t significantly dier in terms
of age and sex ratio, but they obviously diered with regard
to the obesity.
The MO group was then divided depending on the
presence or the absence of hypercapnia (PaCO2 45
mmHg) and on the presence or the absence of obstructive
sleep apnoea (see subsequently). So we obtained three study
subgroups: 1. 24 morbidly obese subjects who were
normocapnic (or hypocapnic) and who didn’t demonstrate
significant obstructive sleep apnoea (O group); 2. 41
morbidly obese subjects who were normocapnic (or
hypocapnic) and who had obstructive sleep apnoea (OSA
group); and 3. 24 morbidly obese subjects with diurnal
hypoventilation (PaCO2 45 mmHg) and who had ob-
structive sleep apnoea (OH group).
In our sample we found no obese subject without
obstructive sleep apnoea, but with diurnal hypercapnia.
PROTOCOL
A complete medical history was recorded and a physical
examination (including neurological, cardiopulmonary,
nose, ear and throat assessment) and a battery of clinicallaboratory tests (including thyroid hormones and electro-
cardiogram) were performed.
QUESTIONNAIRE
All the subjects were interviewed (together with their bed
partners) and then required to fill a comprehensive
questionnaire [a modified version of the Sleep and the
Health Questionnaire (8)] about sleep habits, sleep com-
plaints, snoring and diurnal sleepiness.
ANTHROPOMORPHIC DATA
All the body measurements were performed in the evening
before sleep study. Height and weight were measured and
BMI was calculated. We also determined body superficies
area (BSA). Neck circumference (Neck) was measured at
the level of the cricothyroid membrane; waist circumference
(Waist) was measured midway between the lower rib
margin and the superior anterior iliac spine; hip circumfer-
ence (Hip) was evaluated at the widest circumference over
the great trochanter and the waist hip circumference ratio
(WHR) was also calculated. Body composition was
measured with bioelectrical impedance analysis (BIA) (9,
10) (RSL system inc. electronic instruments computer
system Detroit Michigan, U.S.A.).
RESPIRATORY FUNCTION DATA
A flow–volume spirometry (the best of three measurements)
was performed with the patients in the sitting position using
a pneumotachograph spirometer connected to a micro-
computer system (PK Morgan Ltd., Gillingham, Kent,
England). We used the reference values of Vilijaner (11).
Forced expiratory volume in 1 sec (FEV1) and forced
vital capacity (FVC) were determined and FEV1 as a
percentage of FVC was calculated (FEV1/FVC). Func-
tional residual capacity (FRC), residual volume (RV) and
total lung capacity (TLC) were measured with the helium
equilibration method using a pulmonary function labora-
tory 2400 (Sensor Medics Bilthooem, The Netherlands).
Arterial blood samples for blood gas analysis were drawn
(brachial or radial artery) after at least 10 min of rest in the
supine position.
Arterial blood PaCO2, PaO2, pH and base excess were
analysed with an automatic acid base analyser (ABL30
Radiometer, Copenhagen, Denmark).
All the measures were performed in the evening before
the sleep study.
MEASUREMENT OF SLEEP BREATHING
DISORDERS
All the subjects were evaluated in the sleep laboratory
of the Respiratory Disease Institute, University of Bari
and were monitored continuously for 8 h (22:00–6:00) using
a 12 channel polysomnigraph (Vitalog HMS 5000, Re-
spironics).
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graphic and chin electromyographic recordings were
obtained with surface electrodes according to standard
methods (12).
Airflow was monitored with thermocouples at the nose
and the mouth. Abdominal and ribcage movements were
assessed with respiratory inductive plethysmography with
recording of the paradoxical breathing.
All night long recordings of the oxyhaemoglobin satura-
tion were obtained with a finger pulse oximetry. Moreover
we recorded snoring sound with a microphone attached to
the Neck, electrocardiogram and sleeping position.
A respiratory event (apnoea or hypopnoea) was defined
as a cessation or a reduction of 2/3 in airflow or abdominal-
ribcage movements lasting 10 sec and associated with a
25% decrease in oxygen saturation.
Because most of the events (485%) in our subjects were
obstructive (characterized by cessation or reduction in
airflow and paradoxical breathing), no distinction was
made between the specific patterns of each apnoea in the
analysis.
The total number of the respiratory events was divided
by the total sleep time (TST) to obtain the respiratory
disturbance index (RDI).
RDI  10 h71 was considered a marker of obstructive
sleep apnoea.
We measured baseline arterial oxygen saturation (SaO2
B) during the wakefulness before sleeping while the patient
was in a supine position from 5 min. Oxyhaemoglobinic
desaturation was evaluated in terms of mean nocturnal
oxygen saturation (SaO2M), minimum oxygen saturation
(Nadir) and percentage of TST with oxyhaemoglobin
saturation590% (TSTSaO2590%).
To simplify the analysis, sleep was divided into non rapid
eye movements (NREM) and rapid eyemovements (REM)
sleep; both were expressed as percentage of TST. Sleep
eciency (SE) was defined at TST/time in bed ratio. Sleep
records were scored according to standard criteria (12). The
polysomnography was made after a night of adaptation in
hospital.
All the experimental studies were performed during a
period of relative clinical stability.
STATISTICAL ANALYSIS
We compared MO group with NMO group using chi-
square test and t-test when appropriated.
The comparison among the three subgroups of the
morbidly obese subjects (MO group) was performed with
the analysis of variance or chi-square test when appro-
priated.
All data were expressed as mean+SD.
We used the simple regression analysis to evaluate the
relationship between two variables. A stepwise multiple
regression analysis was performed, attempting to predict
the level of PaCO2. The statistical analysis was performed
using software ‘Statistica for Windows 60’.
A P value less than or equal to 005 was considered to be
of statistical significance.Results
In the MO group we found 65 (73%) subjects aected by
obstructive sleep apnoea; in 24 (27%) of the morbidly obese
group we found obstructive sleep apnoea associated to
hypercapnia; we found no patient with hypercapnia with-
out obstructive sleep apnoea.
On the other hand, in the NMO group we found 126
(64%) subjects with obstructive sleep apnoea; 23 (11%) of
the non-morbidly obese group had obstructive sleep apnoea
associated to hypercapnia; even in this group we found no
patient with hypercapnia without obstructive sleep apnoea.
The chi-square test showed that the prevalence of the
obstructive sleep apnoea was similar into the two groups,
while the percentage of hypercapnia associated with
obstructive sleep apnoea diered between the two groups
(P5001)
We listed the anthropometric characteristics of the three
subgroups of the MO group in the Table 1. Age, height,
weight, BMI, BSA, Neck, Waist, WHR, fat mass % and
smoking history were not significantly dierent among the
three subgroups.
We found a progressive and significant increase of male
percentage from the O to the OH subgroup. Even the Neck
circumference was significantly dierent among the three
subgroups being lower in the O subgroup and bigger in the
OH subgroup.
The evaluation of the results of respiratory function tests
(Table 2) revealed a significant and progressive decrease of
FVC % of pred., FEV1 % of pred. and TLC % of pred.
from the O to the OH subgroup, showing a restrictive
pattern in all the three subgroups.
According to the selection criteria, the PaCO2 value
was higher in the OH subgroup. In view of the recip-
rocal behaviour of O2 and CO2, PaO2 was lower in the OH
subgroup.
With regard to the polysomnographic findings, Table 2
shows that all the measured parameters were significantly
dierent among the three subgroups apart from the sleep
eciency.
The simple regression analysis shows that there was no
significant correlation between PaCO2 and age (r=016,
P=014), BMI (r=008, P=043), Neck (r=018, P=015),
Waist (r=70008, P=096), WHR (r=7009, P=052) or
fat mass % (r=008, P=048) showing that the anthropo-
metric characteristics and the parameters of fat distribution
didn’t correlate to diurnal hypercapnia in morbidly obese
subjects.
There was a significant and negative correlation between
PaCO2 and PaO2 (r=7059, P50001) as expected.
Moreover arterial PaCO2 significantly and negatively
correlated to a number of lung function tests including
FVC % (r=7039, P50001), FEV1 % (r=7045,
P50001) and TLC % (r=7037, P50001), whereas
there was no correlation between PaCO2 and FEV1/FVC
(r=7015, P5019).
With regard to the polysomnographic recordings, there
was significant correlation between PaCO2 and RDI
(r=046, P50001), TSTSaO2590% (r=056, P50001),
Nadir (r=7025,P5005) andSaO2M(r=7059,P5001).
TABLE 1. Anthropometric characteristics in the morbidly obese subjects
Parameters O OSA OH P
Subjects Subjects Subjects value
Number of patients 24 41 24 —
Age (years) 4352+1541 4585+1358 4942+1101 n.s.
Sex M/F 4/20 17/24 15/9 5001*
Weight (kg) 12362+2113 13015+2848 1317+1894 n.s.
Height (cm) 15992+1041 16058+1067 1637+906 n.s.
BMI (kgm72) 4810+361 5041+734 4949+648 n.s.
BSA (m2) 220+026 225+029 229+021 n.s.
Neck (cm) 425+466 4482+392 4736+533 5005
Waist (M) 13758+2125 14272+1767 13842+1246 n.s.
Waist (F) 12845+12 12052+135 12532+100 n.s.
WHR (M) 099+06 101+01 107+016 n.s.
WHR (F) 096+009 097+03 105+01 n.s.
Fat mass% 443+5 4744+75 4526+66 n.s.
Smoke (yes/no) 11/13 16/25 12/12 n.s.
See text for definition of parameters. Quantitative data are expressed as mean+SD and compared using the analysis of
variance
*w2-test.
TABLE 2. Respiratory function tests, arterial blood gas analysis and polysomnographic recordings in morbidly obese subjects
Parameters O OSA OH P
Subjects Subjects Subjects value
FVC % of pred 8725+1814 8237+1693 7327+1481 5005
FVC1 % of pred 9345+2007 8583+1832 7462+1603 5001
FVC/FEV1 % 8918+797 8963+757 8822+1157 n.s.
TLC % of pred 8701+105 7911+1415 6383+1635 5005
PaO2 mmHg 8502+1061 7701+1929 6801+85 500001
PaCO2 mmHg 3649+337 3807+28 4772+23 500001
pH 740+003 739+004 738+002 n.s.
SaO2B % 9634+112 9468+253 9220+326 500001
RDI 498+329 3179+2247 4634+2690 500001
Nadir % 8748+654 7715+118 7468+1142 500001
SaO2M 9417+217 9074+488 8494+579 50001
TSTSaO2590% 822+2212 2595+2934 6340+3386 500001
SE (%) 72+35 700+2 648+34 n.s.
REM stage % 1705+12 140+09 95+12 5005
See text for definition of parameters. Data are expressed as mean+SD and compared using the analysis of variance
TABLE 3. Stepwise multiple regression analysis of diurnal PaCO2
PaCO2=7024 FVC % of pred 7027 FEV1 % of pred +009 TSTSaO2590%+4132
r2=045
TSTSaO2590%=0287 (P50001), FEV1 % of pred=0112 (P5001), FVC % of pred=0065 (P5005)
See text for definition of parameters
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regression analysis) for predicting PaCO2. The r
2 value was
045. TSTSaO2590% contributed to 28%, FEV1 % of pred.
to 11%, FVC % of pred. to 6%.Discussion
The results of the present study show that diurnal
hypercapnia (PaCO2 45 mmHg) and obstructive sleep
244 O. RESTA ET AL.apnoea are more commonly associated in the morbidly
obese subjects than in the non-morbidly obese ones.
Moreover among the morbidly obese subjects, the
hypercapnic ones had a significant higher RDI, a longer
nocturnal desaturation and a more significant ventilatory
restrictive defect than the normocapnic subjects.
Finally, in our sample, no subject had hypercapnia
without obstructive sleep apnoea.
The data on prevalence of diurnal hypercapnia in ob-
structive sleep apnoea are not consistent, ranging between
12 and 37% (5,13,14). Many authors studied patients with
overlap syndrome (obstructive sleep apnoea and COPD)
and most of the authors found that hypercapnia in
obstructive sleep apnoea is COPD related (3,4).
Furthermore the prevalence and the mechanism of
diurnal hypercapnia in the morbidly obese with obstructive
sleep apnoea and without COPD are not well known. In
this work we studied a sample of subjects referred to our
centre because of the suspicion of SRBD: we found that the
prevalence of the hypercapnia associated with obstructive
sleep apnoea in the morbidly obese subjects (BMI 40) was
significantly higher than in the non-morbidly obese ones
(BMI540).
Our results resemble the ones of Laaban (7) who, in a
sample of 24 subjects with similar characteristics (without
other diseases which could explain the hypercapnia) found
that 29% of the subjects had hypercapnia associated with
obstructive sleep apnoea.
In addition this author found in his study that the
ventilatory restriction plays an important role in the
development of the diurnal alveolar hypoventilation in
the subjects with obstructive sleep apnoea and morbid
obesity.
According to the findings of Laaban (7) and Joavery (4)
we found that the OH subjects had a more severe
ventilatory restrictive defect than OSA and O subjects
whereas the values of age, weight, BMI and BSA were
similar.
Other studies (5,15,16) reported the association of
daytime hypercapnia and sleep apnoea and ventilatory
restrictive defect, but the hypercapnic patients were often
significantly heavier.
So, what is the mechanism of the more severe ventilatory
restriction in hypercapnic subjects with obstructive sleep
apnoea compared with normocapnic ones with obstructive
sleep apnoea, when BMI is similar?
Some authors (16) reported a relationship between
ventilatory restriction and fat distribution with abdominal
predominance; but in the literature the data are neither
many nor consistent.
In our study, apart from Neck circumference, we found
no significant dierence among OH, OSA and O subjects in
terms of BSA, Waist, Waist/Hyp ratio, Fat Mass % and
other bioimpedentiometric parameters. Furthermore there
was no relationship between PaCO2 and all these para-
meters of fat distribution.
Some authors (17) in order to explain the ventilatory
restriction, hypothesized a permanent diaphragmatic dys-
function in consequence of hyperventilation episodes
following apnoeas.In addition other authors (18) found that obese subjects
displayed a reduction of the lung and chest wall compliance
and a closure of some peripheral lung units and that these
abnormalities were more severe in the obese with diurnal
hypoventilation.
Whatever the mechanism of the ventilatory restriction is,
our data show that it gives a poor contribution to the
variance of PaCO2 in our morbidly obese subjects.
Several studies (19,20) have shown that these subjects
reverse their awake hypoventilation controlling their sleep
respiratory disturbances with the tracheotomy or with the
nocturnal ventilation, even if these patients did not lose
weight and did not improve their pulmonary functionality.
Furthermore this study and other experiences (2) suggest
that diurnal hypercapnia is rarely associated with morbid
obesity without obstructive sleep apnoea.
The role of sleep respiratory disturbances in the
development of the hypercapnia is rather controversial.
Some authors (5,21) have found that hypercapnia is
significantly related to the severity of the apnoea–hypop-
noea index (RDI); others (7) have found no statistically
significant dierence in terms of RDI between hypercapnic
and normocapnic subjects.
Our results show that the OH subjects had a significantly
higher values of RDI and TSTSaO2590% than OSA subjects
and that TSTSaO2590% was the strongest predictor factor of
diurnal hypercapnia contributing to 28% of the variance of
PaCO2.
The relationship between diurnal PaCO2 and
TSTSaO2590% found in this study is only partially obvious.
It is known that the severity of the oxyhaemoglobinic
desaturations during sleep depends not only on the level of
diurnal baseline SaO2 and PaO2, but also on the nocturnal
hypoventilation which may be present in these patients and
may be independent of the diurnal level of PaCO2. Thus
TSTSaO2590% is an expression of the severity of sleep
related respiratory disturbances (apnoeic–hypoapnoeic
events and hypoventilation).
Even though the low value of r2 of the multiple regression
equation suggests that other factors not investigated in this
study are involved with the development of diurnal
hypercapnia, our findings emphasize the relationship
between the occurrence of hypercapnia in morbidly obese
subjects and the presence of a restrictive ventilatory pattern
and the severity of the sleep linked respiratory disturbances.
From this point of view, many authors (6,22,23) have
suggested that severe sleep-linked respiratory disturbances
could induce a depression of the respiratory drive. Several
studies have reported a reduced or defective ventilatory
response to both hypercapnia and hypoxia in those subjects
with obstructive sleep apnoea and hypercapnia, whereas
this response was normal in those subjects with obstructive
sleep apnoea without hypercapnia (6,19,22). Thus, Piper et
al. (23) hypothesized that during the periods of apnoea and
hypoventilation, CO2 tension rises and remains elevated
during the periods of obstruction. In patients with a normal
function of the carotid bodies, such changes in blood gas
values could stimulate hyperventilation, bringing CO2
tension to the normal range between these periods.
However, in those patients with a depressed ventilatory
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severe ventilatory restrictive defect, there would be less
respiratory eort with a reduction of the ventilatory
response after the apnoeic or hypopneic events with a
consequent increase of the length of the hypercapnia and
the desaturation periods.
Finally chronic nocturnal hypoxaemia and hypercapnia
associated with sleep fragmentation may further depress the
arousal response to chemical stimuli and contribute to
prolong the cycles with depression of the ventilatory drive,
resulting in diurnal hypoventilation. In these subjects the
relief from severe respiratory disturbances in sleep can lead
to a better spontaneous ventilatory drive both when awake
and asleep (23,24).
CONCLUSION
In conclusion, our study showed that diurnal hypercapnia
is frequently associated with obstructive sleep apnoea in
morbidly obese subjects without COPD.
Moreover, our data showed that ventilatory restriction
and sleep linked respiratory disturbances are correlated to
diurnal alveolar hypoventilation. Neither body weight, nor
amount of fat mass nor fat distribution seem to play any
important role in the development of hypercapnia.
However, further studies are requested to verify other
parameters, we did not consider in this study.
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